01 1ACETAMINOPHEN; CODEINE PHOSPHATE
02 2ACETAMINOPHEN; HYDROCODONE BITARTRATE
03 2AMCINONIDE
04 1ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE
05 2ASPIRIN; OMEPRAZOLE
06 2CARBINOXAMINE MALEATE
07 2CHLORPROMAZINE HYDROCHLORIDE
08 2CLEMASTINE FUMARATE
09 2HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
10 1HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE
11 2INDOMETHACIN
12 2ISONIAZID
13 2ISOSORBIDE MONONITRATE
14 12LEVOTHYROXINE SODIUM
15 4MEPERIDINE HYDROCHLORIDE
16 1METOCLOPRAMIDE HYDROCHLORIDE
17 2MORPHINE SULFATE
18 1NYSTATIN
19 3OXYCODONE HYDROCHLORIDE
20 1PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
21 5POTASSIUM CHLORIDE
22 1PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
01 1AEROSOL, METERED;TOPICAL
02 3CAPSULE;ORAL
03 2CONCENTRATE;ORAL
04 1CREAM;TOPICAL
05 3FOR SOLUTION;ORAL
06 1OINTMENT;TOPICAL
07 1SOLUTION/DROPS;OPHTHALMIC
08 9SOLUTION;ORAL
09 1SUSPENSION;ORAL
10 3SYRUP;ORAL
11 2TABLET, DELAYED RELEASE;ORAL
12 26TABLET;ORAL
01 10.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
02 10.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
03 10.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
04 10.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
05 20.1%
06 10.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
07 10.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
08 10.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
09 10.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
10 10.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
11 10.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
12 10.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
13 10.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
14 11%;1%
15 11.5MG/5ML;5MG/5ML
16 11.5MG;5MG
17 1100,000 UNITS/ML
18 2100MG
19 1100MG/5ML
20 1100MG/ML
21 110MEQ
22 110MG
23 1120MG/5ML;12MG/5ML
24 1150MG
25 115MG
26 12.68MG
27 120MEQ
28 120MEQ/15ML
29 220MG
30 1300MG
31 130MG
32 130MG/ML
33 2325MG/15ML;7.5MG/15ML
34 1325MG;200MG;16MG
35 1325MG;40MG
36 140MEQ
37 140MEQ/15ML
38 140MG
39 14MG
40 14MG/5ML
41 150MG
42 15MG
43 15MG/5ML
44 15MG/5ML;6.25MG/5ML
45 175MG
46 181MG;40MG
47 1EQ 0.23% PHOSPHATE;10%
48 1EQ 0.5MG BASE/5ML
49 1EQ 5MG BASE/5ML
01 16DISCN
02 37RX
RLD : No
TE Code :
ACETAMINOPHEN; CODEINE PHOSPHATE
Dosage Form : SOLUTION; ORAL
Proprietary Name : ACETAMINOPHEN AND CODEIN...
Dosage Strength : 120MG/5ML;12MG/5ML
Approval Date : 1982-01-01
Application Number : 87508
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code : AA
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : SOLUTION; ORAL
Proprietary Name : HYDROCODONE BITARTRATE A...
Dosage Strength : 325MG/15ML;7.5MG/15ML
Approval Date : 2011-07-19
Application Number : 40894
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Dosage Form : SOLUTION; ORAL
Proprietary Name : HYDROCODONE BITARTRATE A...
Dosage Strength : 325MG/15ML;7.5MG/15ML
Approval Date : 2012-01-25
Application Number : 200343
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Dosage Form : CREAM; TOPICAL
Proprietary Name : AMCINONIDE
Dosage Strength : 0.1%
Approval Date : 2003-05-15
Application Number : 76065
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Dosage Form : OINTMENT; TOPICAL
Proprietary Name : AMCINONIDE
Dosage Strength : 0.1%
Approval Date : 2002-11-19
Application Number : 76096
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code :
ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE
Dosage Form : TABLET; ORAL
Proprietary Name : CARISOPRODOL, ASPIRIN AN...
Dosage Strength : 325MG;200MG;16MG
Approval Date : 2010-01-07
Application Number : 40860
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Proprietary Name : YOSPRALA
Dosage Strength : 81MG;40MG
Approval Date : 2016-09-14
Application Number : 205103
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Proprietary Name : YOSPRALA
Dosage Strength : 325MG;40MG
Approval Date : 2016-09-14
Application Number : 205103
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code : AA
Dosage Form : TABLET; ORAL
Proprietary Name : CARBINOXAMINE MALEATE
Dosage Strength : 4MG
Approval Date : 2003-03-19
Application Number : 40442
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
RLD : No
TE Code :
Dosage Form : SOLUTION; ORAL
Proprietary Name : CARBINOXAMINE MALEATE
Dosage Strength : 4MG/5ML
Approval Date : 2003-04-25
Application Number : 40458
RX/OTC/DISCN : RX
RLD : No
TE Code :
Genus Lifesciences is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Indomethacin bulk offered by Genus Lifesciences
